Towards Financial Freedom

Riverstone Holdings - Record Performance

kiasutrader
Publish date: Sat, 09 Nov 2013, 11:51 PM
Riverstone's  3QFY13  results  beat  our  expectations,  with  PATMI  of MYR15.69m (+49.3% y-o-y) and topline revenue of MYR93.99m (+18.9% y-o-y),  underpinned  by  its  capacity expansion and growing demand for its products.  The group  is on track  for  a  strong  FY13 performance  and beyond.  Reiterate  BUY,  with  a  SGD1.05  TP,  based  on  16.3x  industry average blended forward FY13/14 P/E.
  • Record  performance.  Riverstone  posted  record  3Q13  results, underpinned  by  the  expansion  in  its  production  capacity  and  overall growing  demand  for  its  products,  particularly  in  the  healthcare  gloves segment.  Net margins increased by 3.4 ppts y-o-y to 16.7%, higher than our  FY13  full-year  estimates  of  15.4%,  mainly  attributed  to:  i)  a  higher utilisation rate (91%), ii) favourable raw material prices, and iii) a reversal of  forex  losses  of  MYR1.1m  in  3Q12  to  a  gain  of  MYR0.2m  in  this quarter.
  • Solid outlook as growth story plays out.  Nitrile gloves, which remove the  problem  of  latex  sensitivity,  continue   to  gain  popularity  and  are expected  to  grow  by  14%  globally.  This  should  boost  growth  for  its healthcare  products.  Meanwhile,  we  expect  robust  demand  for  its cleanroom products  given the  stable hard disk drive outlook  as well as favourable  prospects for  the semiconductor and wireless devices   sector. With  its  current  production  plant  now  at  full  capacity,  the  group  is currently  building  a  new  site,  with  1.0bn  pieces/annum  of  additional capacity expected to come online in 2HFY14,  thus  providing support  for future growth.
  • Proposed  delisting  of  Medi-flex  supports  undervalued  thesis.  The recent  delisting  offer  by  Top  Glove  (TOPG  MK,  NEUTRAL,  TP: MYR6.34)  of  its  indirect  80%-owned  Singapore-listed  subsidiary  Mediflex  values  the  latter  at  14.5x  FY13  P/E  (SGD1:MYR2.56).  Despite trading at a lower FY13 P/E,  Riverstone, which boasts about  10x larger net  cash  hoards,  is  expected  to  generate  twice  the  profit.  The  group's essential nitrile  manufacturing  know-how  -  especially in the cleanroom space - coupled with its  growth potential, will make it a favourable target for acquisition.
Financial Exhibits
SWOT Analysis
Company Profile
Riverstone Holdings specialises in producing and selling nitrile gloves used in the clean-room manufacturing and healthcare industry.
Recommendation Chart
Source: OSK
Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment